Showing 5,961 - 5,980 results of 24,408 for search '(( e point decrease ) OR ( 100 ((nn decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 0.97s Refine Results
  1. 5961
  2. 5962

    Patterns of lifetime use of substances by gender. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…</b> Four hundred students, 100 from each of the 4 institutions; selected through a stratified multi-stage random sampling, who gave consent to participate in the study. …”
  3. 5963

    S1 Data - by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…</b> Four hundred students, 100 from each of the 4 institutions; selected through a stratified multi-stage random sampling, who gave consent to participate in the study. …”
  4. 5964

    Factors associated with substance use. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…</b> Four hundred students, 100 from each of the 4 institutions; selected through a stratified multi-stage random sampling, who gave consent to participate in the study. …”
  5. 5965

    Factors associated with personality traits. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…</b> Four hundred students, 100 from each of the 4 institutions; selected through a stratified multi-stage random sampling, who gave consent to participate in the study. …”
  6. 5966

    Expression levels of genes involved in glycolysis upon treatment with 10058-F4. by Muhammad Mushtaq (788834)

    Published 2015
    “…<p>Expression levels of a set of genes (<i>GLUTI</i>, <i>HK</i>, <i>LDHA</i>, <i>MCT4</i>, <i>PDK1</i>, <i>PGK1</i>, and <i>PKM2</i>) were assessed by Q-PCR after the treatment of cells with 100 μM of 10058-F4 for 4 h. …”
  7. 5967
  8. 5968
  9. 5969
  10. 5970

    Loss of <i>Tuba1a</i> leads to altered patterns of neurogenesis and migration. by Elizabeth Bittermann (7140338)

    Published 2019
    “…In comparison to wild-type cells at E14.5 (n = 4 wild-type and mutant embryos), the number of <i>Tuba1a</i> mutant total EdU+ cells are reduced (K), EdU-Ki67+ cells are increased (L), EdU+Ki67+ cells are increased (M) and the quit fraction (EdU+Ki67-/EdU+) is decreased (N). …”
  11. 5971
  12. 5972

    S1 Graphical abstract - by Eduardo J. Aguilar-Rangel (18349662)

    Published 2024
    “…While the <i>amoA</i>-AOA: <i>amoA</i>-AOB ratio decreased from 9.8 in rainfed soils to 1.6 in soils irrigated for 100 years, indicating a favoring environment for AOB rather than AOA. …”
  13. 5973
  14. 5974

    Table 1_Gamma knife radiosurgery for cerebral cavernous malformations: biologically effective dose predicts therapeutic outcomes.docx by Xiaoman Shi (12587770)

    Published 2025
    “…During follow-up, 13 patients (10.6%) experienced hemorrhage and AHR decreased from 13.6 to 4.3% per 100 lesion-years (IRR = 0.314; p < 0.001). …”
  15. 5975
  16. 5976

    Q76A and F80A substitutions in Vpx disrupt ability of SIVmac 239 to transduce macrophages. by Smita Srivastava (271962)

    Published 2008
    “…<p>(A) Q76A and F80A substituted Vpx are efficiently incorporated into SIVmac virions. …”
  17. 5977
  18. 5978

    Change of colocalization of Sig1R-YFP and KDEL-mRFP caused by (+)-pentazocine. by Sergei Kopanchuk (6406085)

    Published 2022
    “…Scale bar = 1 μm. A time-dependent decrease in spot coupling was observed between Sig1R-YFP and KDEL-mRFP after activation of Sig1R with 100 nM (+)-pentazocine (middle image). …”
  19. 5979

    Table_1_Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant.docx by Karin Eytan (13444422)

    Published 2022
    “…The combined treatment increased the phosphorylation of eIF2α (P-eIF2α) relative to each drug alone and enhanced the decrease in cell survival. …”
  20. 5980

    Table 1_Targeting nail psoriasis: IL-17A inhibitors demonstrate site-specific superiority over IL-23 inhibitor in a 24-week dermoscopy-guided real-world cohort.docx by Xiamei Yan (21014921)

    Published 2025
    “…Objective<p>To compare the real-world clinical efficacy and safety of interleukin (IL)-17A inhibitors (secukinumab [SEC] and ixekizumab [IXE]) versus the IL-23 inhibitor guselkumab (GUS) in patients with nail psoriasis, with a focus on site-specific biologic therapeutic responses (nail matrix vs. nail bed) in a 24-week prospective observational cohort.…”